drugset / Trial / NCT03925818
Low Dose Bismuth Versus Lactobacillus Reuteri for H. Pylori Eradication
RandomizedParallel-groupOpen-labelTreatment
Summary
This study investigates the efficacy of a b.i.d. quadruple therapy containing Pylera® or L. reuteri for H. pylori infection.
Timeline
- Start
- 2017-08-29
- Primary completion
- 2018-11-29
- Completion
- 2018-12-23
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | bismuth subcitrate | Unknown | 140 mg | — |